Cohen Cheryl insider trades
Cohen Cheryl has filed 17 Form 4s with the SEC that we hold, for ImmunityBio, Inc. (IBRX) (Director), Celldex Therapeutics, Inc. (CLDX) (Director), Lite Strategy, Inc. (MEIP) (Director) and Whitehawk Therapeutics, Inc. (ARPO) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $2.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($2.1M). The largest single trade was a sale of 131,210 shares of ImmunityBio, Inc. worth $1.2M, dated 2026-07-02. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-02 and the latest 2026-10-06.
ImmunityBio, Inc. (IBRX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-17 | S, sale reported on Form 4 | 43,398 | $439.2K | 2021-08-19 | SEC |
| 2021-08-18 | S, sale reported on Form 4 | 2,133 | $21.4K | 2021-08-19 | SEC |
| 2021-08-20 | S, sale reported on Form 4 | 9,976 | $99.8K | 2021-08-24 | SEC |
| 2021-08-23 | S, sale reported on Form 4 | 14,801 | $149.8K | 2021-08-24 | SEC |
| 2026-07-02 | S, sale reported on Form 4 | 131,210 | $1.2M | 2026-07-06 | SEC |
| 2026-10-02 | S, sale reported on Form 4 | 81,056 | $851.1K | 2026-10-06 | SEC |
Celldex Therapeutics, Inc. (CLDX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Lite Strategy, Inc. (MEIP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Whitehawk Therapeutics, Inc. (ARPO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1529371) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
